Rubio Assures NATO Allies on US Troop Deployment Plans Amid Policy Uncertainty
Solar Panel Sales Surge as Businesses Seek LongTerm Energy Cost Savings
Anthropic and Microsoft Discuss AI Chip Deal Following 5 Billion Investment
Wingstop Shares Drop 12 After Earnings Miss Profit Expectations
AI Talent Wars How Tech Giants and Startups Are Battling for the Future of Artificial Intelligence
CPF LIFE vs SelfInvesting Retirement Decision Hinges on Financial Management in Old Age
ArtsWay Manufacturing ARTW Q4 2024 Earnings Positive EPS Despite Market Headwinds
Concord Medical Services CCM Q2 2016 Earnings EPS Falls Well Below Estimates as Stock Defies Negative Surprise
ABT Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Lower
MXC Q3 2025 Earnings Positive EPS of 022 Amid Quiet Quarter
PubMatic Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher
ERII Q1 2026 Earnings EPS Miss Highlights Ongoing Cost Pressures Despite Stock Gain
Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally
Lifevantage LFVN Surges Over 23 Key Levels to Watch After the Breakout
DuPont DD Plunges 39 as Key Support Level Approaches What Investors Should Know
Seanergy Maritime SHIP Slides 23 as Dry Bulk Sector Faces Headwinds Support at 1412 in Focus
Trilogy Metals Inc TMQ Edges Higher as Price Nears Resistance Zone
World Cup Campaigns May Be Reshaping Consumer Spending on Food Apparel and Travel
Estee Lauder EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge
Materion Corporation MTRN Holds Steady Near Support Amid Marginal Decline
Norfolk Southern NSC Slides Over 45 as Support Levels Come into Focus
TMobile US Senior Notes TMUSI Edge Higher Yield Considerations and Key Levels
Banco Bradesco BBD Edges Higher as Support Holds Key Levels to Watch
NVIDIA Edges Higher as Support Holds Steady
TH International THCH Edges Higher Consolidating Between Support and Resistance
RXO Inc RXO Holds Steady Near Resistance as Trading Volume Signals Caution
Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback